Utah Medical Products (UTMD) Raw Materials (2011 - 2025)

Utah Medical Products' Raw Materials history runs 15 years deep, the most recent figure standing at $5.1 million for Q4 2025.

• On a quarterly basis, Raw Materials fell 7.29% year-over-year to $5.1 million in Q4 2025; TTM through Dec 2025 was $5.1 million, a 7.29% decrease from a year earlier, with the FY2025 full-year figure at $5.1 million, down 7.29% from the prior year.
• Raw Materials retreated to $5.1 million in Q4 2025 per UTMD's latest filing, from $5.5 million in the prior quarter.
• Across five years, Raw Materials topped out at $6.5 million in Q1 2023 and bottomed at $3.4 million in Q3 2021.
• The 5-year median for Raw Materials is $5.5 million (2024), against an average of $5.2 million.
• Across the five-year window, Raw Materials slipped 15.7% in 2021 and soared 61.25% in 2023, its largest moves.
• Year by year, Raw Materials stood at $3.7 million in 2021, then jumped by 53.49% to $5.7 million in 2022, then increased by 11.69% to $6.4 million in 2023, then declined by 14.22% to $5.5 million in 2024, then retreated by 7.29% to $5.1 million in 2025.
• Per Business Quant, the three latest UTMD Raw Materials figures stand at $5.1 million (Q4 2025), $5.5 million (Q4 2024), and $6.3 million (Q3 2024).